SCHEMBL29544697

SCHEMBL29544697

CC(C)(C)OC(=O)Nc1cc2c(O)ccnc2cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.44
DYRK1A Q13627 1/20 0.44
ATR Q13535 1/20 0.41
MAP4K4 O95819 1/20 0.39
MAPK1 P28482 1/20 0.39
IGF1R P08069 1/20 0.37
SYK P43405 1/20 0.37
NAMPT P43490 1/20 0.37
CDK9 P50750 1/20 0.36
SREBF2 Q12772 1/20 0.36
CYP17A1 P05093 1/20 0.36
PIK3CD O00329 1/20 0.36
ABL1 P00519 1/20 0.36
EGFR P00533 1/20 0.36
HCK P08631 1/20 0.36
SRC P12931 1/20 0.36
KDR P35968 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544791 0.79 MET (0.39) GSK3BDYRK1AATRMAPK1IGF1R
SCHEMBL29545017 0.79 CYP2C9 (0.49) GSK3BDYRK1AMAPK1CDK9EGFR
SCHEMBL1192656 0.76 ATR (0.50) GSK3BDYRK1AATRMAP4K4IGF1R
SCHEMBL30953487 0.76 ATR (0.50) GSK3BDYRK1AATRMAP4K4IGF1R
SCHEMBL30381790 0.75 GSK3B (0.50) GSK3BDYRK1AATRMAPK1SYK
SCHEMBL828560 0.74 TP53 (0.51) MEN1NPC1RAB9AKMT2A
SCHEMBL23510740 0.73 GSK3B (0.45) GSK3BDYRK1AATRMAPK1IGF1R
SCHEMBL31637747 0.72 GSK3B (0.47) GSK3BDYRK1AATRMAPK1IGF1R
SCHEMBL7909650 0.72 ATR (0.46) GSK3BDYRK1AATRMAP4K4IGF1R
SCHEMBL1133582 0.72 ATR (0.46) GSK3BDYRK1AATRIGF1RCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed